Finance

Lists
Q2 2026 earnings • released • Revenue miss -0.67%
See results
CLN:WSE
Celon Pharma SA
PLN 19.80
-4.81%
(-1.00) 1D
Sep 18, 5:04:50 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
PLN 20.40
High
PLN 20.95
Low
PLN 19.76
Mkt. cap
1.07B
Avg. vol.
17.47K
Volume
45.06K
P/E ratio
9.89
52-wk high
PLN 23.50
52-wk low
PLN 18.50
EPS
PLN 2.00
Shares outstanding
53.91M
No. of employees
564
Open
PLN 20.40
High
PLN 20.95
Low
PLN 19.76
Mkt. cap
1.07B
Avg. vol.
17.47K
Volume
45.06K
P/E ratio
9.89
52-wk high
PLN 23.50
52-wk low
PLN 18.50
EPS
PLN 2.00
Shares outstanding
53.91M
No. of employees
564
About Celon Pharma SA
CEO-
Employees564
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitecelonpharma.com
Last report
Sep 16, 2026
Fiscal period
Q2 2026
EPS / Est. (PLN)
- / -
Revenue / Est. (PLN)
60.09M / 60.50M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
55.82M
71.13M
66.67M
61.29M
Cost of goods sold
20.26M
16.83M
11.54M
16.70M
Cost of revenue
20.26M
16.83M
11.54M
16.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.01M
33.02M
35.44M
36.08M
Operating expense
52.22M
46.24M
52.60M
50.56M
Total operating expenses
72.48M
63.07M
64.14M
67.26M
Operating income
-16.67M
8.06M
2.53M
-5.98M
Other non operating income
-
-30.00K
-250.00K
169.12M
EBT including unusual items
-26.84M
-2.77M
-6.57M
160.34M
EBT excluding unusual items
-26.84M
-2.77M
-6.57M
160.34M
Income tax expense
5.92M
-6.43M
18.33M
-2.26M
Effective tax rate
-22.05%
232.29%
-279.14%
-1.41%
Other operating expenses
5.98M
2.20M
6.37M
3.36M
Net income
-32.76M
3.66M
-24.90M
162.60M
Net profit margin
-58.70%
5.15%
-37.35%
265.30%
Earnings per share
-
-
-
-
Interest and investment income
550.00K
-
149.00K
151.00K
Interest expense
-304.00K
-
-341.00K
-497.00K
Net interest expenses
246.00K
-
-192.00K
-346.00K
Depreciation and amortization charges
11.23M
11.01M
10.78M
11.13M
EBITDA
-8.28M
16.34M
11.40M
3.44M
Gain or loss from assets sale
2.53M
-170.00K
-2.91M
-569.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps